Barclays PLC Affimed N.V. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023
SELL
$0.57 - $1.08 $47,334 - $89,686
-83,043 Reduced 52.49%
75,169 $45,000
Q1 2023

May 04, 2023
BUY
$0.66 - $1.29 $28,624 - $55,947
43,370 Added 37.76%
158,212 $117,000
Q4 2022

Feb 13, 2023
BUY
$1.1 - $2.45 $23,786 - $52,978
21,624 Added 23.2%
114,842 $142,000
Q3 2022

Nov 03, 2022
BUY
$1.96 - $3.32 $21,387 - $36,227
10,912 Added 13.26%
93,218 $192,000
Q2 2022

Aug 12, 2022
BUY
$2.27 - $4.86 $30,170 - $64,594
13,291 Added 19.26%
82,306 $228,000
Q1 2022

May 16, 2022
SELL
$3.69 - $5.65 $430,833 - $659,677
-116,757 Reduced 62.85%
69,015 $302,000
Q4 2021

Feb 14, 2022
SELL
$5.37 - $7.07 $21,689 - $28,555
-4,039 Reduced 2.13%
185,772 $1.03 Million
Q3 2021

Nov 09, 2021
BUY
$5.54 - $7.51 $391,567 - $530,806
70,680 Added 59.33%
189,811 $1.17 Million
Q2 2021

Aug 13, 2021
SELL
$7.78 - $11.4 $511,270 - $749,162
-65,716 Reduced 35.55%
119,131 $1.01 Million
Q1 2021

May 13, 2021
BUY
$5.12 - $8.48 $557,675 - $923,650
108,921 Added 143.46%
184,847 $1.46 Million
Q4 2020

Feb 11, 2021
SELL
$3.16 - $7.03 $131,730 - $293,059
-41,687 Reduced 35.44%
75,926 $442,000
Q3 2020

Nov 12, 2020
BUY
$3.26 - $4.73 $23,149 - $33,587
7,101 Added 6.43%
117,613 $399,000
Q2 2020

Aug 12, 2020
BUY
$1.58 - $4.63 $71,368 - $209,137
45,170 Added 69.13%
110,512 $510,000
Q1 2020

May 13, 2020
SELL
$1.44 - $3.02 $27,758 - $58,216
-19,277 Reduced 22.78%
65,342 $104,000
Q4 2019

Feb 10, 2020
BUY
$2.25 - $3.07 $99,229 - $135,393
44,102 Added 108.85%
84,619 $232,000
Q3 2019

Nov 14, 2019
SELL
$2.67 - $3.65 $24,387 - $33,339
-9,134 Reduced 18.4%
40,517 $119,000
Q2 2019

Aug 14, 2019
BUY
$2.6 - $4.21 $42,663 - $69,081
16,409 Added 49.36%
49,651 $142,000
Q1 2019

May 15, 2019
SELL
$3.05 - $4.34 $133,336 - $189,731
-43,717 Reduced 56.81%
33,242 $139,000
Q4 2018

Feb 14, 2019
BUY
$2.82 - $4.67 $56,952 - $94,315
20,196 Added 35.58%
76,959 $240,000
Q3 2018

Nov 14, 2018
BUY
$1.45 - $6.15 $62,898 - $266,774
43,378 Added 324.08%
56,763 $247,000
Q2 2018

Aug 14, 2018
SELL
$1.65 - $2.5 $85,095 - $128,932
-51,573 Reduced 79.39%
13,385 $22,000
Q1 2018

May 15, 2018
BUY
$1.25 - $2.65 $64,466 - $136,668
51,573 Added 385.3%
64,958 $120,000
Q3 2017

Nov 14, 2017
BUY
$1.95 - $2.25 $26,100 - $30,116
13,385
13,385 $30,000

Others Institutions Holding AFMD

# of Institutions
3
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About Affimed N.V.

AFMD Quotes by TradingView
  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $520M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email